The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin.
Saved in:
| Title: | The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin. |
|---|---|
| Authors: | Deloizy C; VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France.; GenoSafe, 1 bis rue de l'International, 91000, Evry, France., Fossum E; K.G. Jebsen Center for Influenza Vaccine Research, University of Oslo and Oslo University Hospital, 0027, Oslo, Norway., Barnier-Quer C; Vaccine Formulation Laboratory, University of Lausanne, Chemin des Boveresses 155, 1066, Epalinges, Switzerland., Urien C; VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France., Chrun T; VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France., Duval A; VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France.; Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases (B2PHI), Inserm, UVSQ, Institut Pasteur, Université Paris-Saclay, 78180, Montigny-le-Bretonneux, France., Codjovi M; VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France.; Genfit, 885 Avenue Eugène Avinée, 59120, Loos, France., Bouguyon E; VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France., Maisonnasse P; VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France.; CEA - Université Paris Sud 11 - INSERM U1184, Immunology of Viral infections and Autoimmune Diseases (IMVA), IDMIT infrastructure, 92265 Fontenay-aux-Roses, France., Hervé PL; VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France.; DBV Technologies, 177-181 avenue Pierre Brossolette, 92120, Montrouge, France., Barc C; UE1277-INRA, Plate-Forme d'Infectiologie Expérimentale - PFIE, 37380, Nouzilly, France., Boulesteix O; UE1277-INRA, Plate-Forme d'Infectiologie Expérimentale - PFIE, 37380, Nouzilly, France., Pezant J; UE1277-INRA, Plate-Forme d'Infectiologie Expérimentale - PFIE, 37380, Nouzilly, France., Chevalier C; VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France., Collin N; Vaccine Formulation Laboratory, University of Lausanne, Chemin des Boveresses 155, 1066, Epalinges, Switzerland., Dalod M; Aix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, 13288, Marseille, France., Bogen B; K.G. Jebsen Center for Influenza Vaccine Research, University of Oslo and Oslo University Hospital, 0027, Oslo, Norway.; Center for Immune Regulation, Institute of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, 0424, Oslo, Norway., Bertho N; VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France., Schwartz-Cornil I; VIM-INRA-Université Paris-Saclay, Domaine de Vilvert, 78350, Jouy-en-Josas, France. isabelle.schwartz@inra.fr. |
| Source: | Scientific reports [Sci Rep] 2017 Aug 09; Vol. 7 (1), pp. 7639. Date of Electronic Publication: 2017 Aug 09. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
